Comparative statistics by cancer registry
Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
(Kampala, Uganda, 1993-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | Total | Absolute survival % | Relative survival % | ASRS% at 5-years | ||||||
| 1-year | 3-year | 5-year | 1-year | 3-year | 5-year | all ages | 0-74 years | ||||
| C11 | Nasopharynx | 49 | 58.5 | 27.2 | 0.0 | 59.8 | 29.0 | 0.0 | 0.0 | 0.0 | |
| C15 | Oesophagus | 180 | 36.5 | 10.3 | 2.5 | 38.3 | 12.3 | 3.4 | 4.6 | 3.0 | |
| C16 | Stomach | 90 | 39.1 | 7.5 | 0.0 | 40.9 | 8.5 | 0.0 | 0.0 | 0.0 | |
| C18 | Colon | 51 | 54.3 | 19.0 | 5.4 | 57.2 | 22.7 | 7.4 | 6.2 | 8.2 | |
| C19-20 | Rectum | 50 | 56.0 | 13.7 | 9.1 | 58.4 | 15.4 | 11.0 | 7.2 | 10.1 | |
| C22 | Liver | 116 | 33.0 | 8.0 | 2.7 | 34.0 | 8.7 | 3.1 | 1.1 | 1.4 | |
| C33-34 | Lung | 47 | 15.9 | 0.0 | 0.0 | 16.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| C46 | Kaposi sarcoma | 370 | 58.5 | 33.8 | 18.6 | 59.7 | 36.1 | 20.8 | 21.9 | 35.6 | |
| C50 | Breast | 162 | 72.0 | 54.3 | 37.8 | 74.5 | 59.3 | 44.0 | 36.1 | 45.8 | |
| C53 | Cervix | 283 | 73.0 | 34.9 | 17.1 | 75.0 | 37.8 | 19.8 | 18.7 | 13.1 | |
| C56 | Ovary | 66 | 44.3 | 28.5 | 13.7 | 45.5 | 31.4 | 16.1 | 10.2 | 8.6 | |
| C61 | Prostate | 154 | 86.6 | 56.2 | 29.4 | 95.0 | 75.3 | 48.1 | 45.6 | 47.2 | |
| C69 | Eye | 81 | 92.4 | 55.1 | 30.4 | 94.3 | 58.4 | 33.4 | 35.7 | 35.7 | |
| C73 | Thyroid | 39 | 62.3 | 26.7 | 8.9 | 63.8 | 28.7 | 10.2 | 10.8 | 10.8 | |
| C82-85+C96 | Non-Hodgkin lymphoma | 178 | 61.4 | 40.7 | 31.9 | 62.3 | 42.2 | 33.6 | 26.1 | 25.1 | |
Graphs:
 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |